Full Press Release Details
Ms. Yamamura has several years of experience with a broad range of disease models of inflammation, immunology, and oncology. She attended Colgate University where she studied Cellular Neuroscience and Psychology.
IMRX Positive Sentiment
Amy Yamamura
Key Takeaway: Ms. Amy Yamamura brings years of experience in disease models related to inflammation, immunology, and oncology. She studied Cellular Neuroscience and Psychology at Colgate University, equipping her with a strong academic background for her role.
Price reaction · baseline $6.73 (2025-12-26 close) · 15 other IMRX headline(s) in the window, move may be shared
day 0 close · peak
-1%
Market Sentiment Analysis
POSITIVE FACTORS
- Ms. Yamamura has extensive experience in various disease models.
- Her background includes expertise in inflammation, immunology, and oncology.
- She has a strong academic foundation in Cellular Neuroscience and Psychology.
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+41%
120-day peak, hindsight
Typical move
11.4%
average across 8 past catalysts
Cash runway
~36 mo
Minimal dilution risk
Lead asset
IMM-1-104 Monotherapy
Phase 1 · Advanced Solid Tumor
Frequently Asked Questions
What is Amy Yamamura's educational background?
Amy Yamamura studied Cellular Neuroscience and Psychology at Colgate University.
What areas does Ms. Yamamura specialize in?
She specializes in inflammation, immunology, and oncology disease models.
How many years of experience does Ms. Yamamura have?
Ms. Yamamura has several years of experience in her field.